Visit iDataResearch.com
  Monthly Medtech Newsletter
  July 2018
 
Feature Story:

Psoriasis Treatments to Become Cheaper as Biosimilars Compete in $5 Billion U.S. Psoriasis Drugs Market – New Study by iData Research

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis (PsO) every year in the United States, affecting 2.2% of the population. Approximately 80% of those affected have mild-to-moderate psoriasis, while 20% have moderate-to-severe psoriasis, which is often treated with immunology drugs. These drugs command a high price, but there may be hope for better options in the future. People with...

Read more about this study

Recent Events in the Continuous Glucose Monitoring Diabetes Market

FDA Approves First Continuous Glucose Monitoring System with Fully Implantable Glucose Sensor & Compatible Mobile App The U.S. Food and Drug Administration approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, which can be worn for up to 90 days. The Eversense CGM system uses a small sensor that is implanted just under the skin by a qualified health care provider during an outpatient procedure. After it is implanted, the sensor regularly...

read more}

 

Itamar Medical Launches SleePath™, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool

Itamar Medical Ltd., an industry leading company that develops, manufactures, and markets sleep apnea management solutions with focus on the cardiology market, announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring system that allows cardiologists to monitor patients with atrial fibrillation (AF) sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices on demand. Effective management of sleep apnea is essential for improving outcomes in patients with AF, a type of irregular heartbeat that affects 6 million individuals in the United States. Sleep apnea occurs in roughly...

read more}

 

Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Woundss

Australian stem cell and regenerative medicine company Cynata Therapeutics Limited is pleased to announce that it has received positive data demonstrating the efficacy of its Cymerus™ mesenchymal stem cells (MSCs) in a preclinical model of diabetic wounds (also known as diabetic ulcers). The studies were conducted independently by the Cooperative Research Centre for Cell Therapy Manufacturing (CTM CRC) and were designed to compare cells from various sources. Key Highlights: – Cymerus MSCs resulted in...

read more}

 

Surgical.AI Completes $20-Million Investment in Caresyntax, Raising Caresyntax’s Total First Round Financing to $31.9 Million

Caresyntax, a surgical data, analytics and automation company, announced it has successfully concluded its first funding round with a total of $31.9 million in collected funds. Norgine Ventures, a European business supporting innovative healthcare companies with debt-like financing, provided caresyntax with financing of up to €10 million ($11.9 million), and surgical.AI, a Berlin and Boston-based specialized healthcare artificial intelligence (AI) investor, invested $20 million. Caresyntax will use this financing to ...

read more}

 

Will Humira Competitors Take Over the Immunology Drugs Market?

In a new series of reports by iData Research, it was revealed that in 2017, the U.S. immunology market was valued at over $34 billion. A major portion of this revenue came from the biologic Humira, which accounted for over one-third of the total market value. Humira is one of the most expensive biotherapies on the market, with a typical patient cost between $1,100 and $2,600 per month. The actual drug, marketed under the brand name Humira, is called adalimumab, and was originally...

read more}

 

Is There an End in Sight for J&J Divestitures?

Johnson & Johnson has received an offer for its sterilization unit. The New Brunswick, NJ-based company said Fortive is seeking to acquire the business for $2.7 billion. The sterilization business is part of the Ethicon division and earned about $775 million in sales in 2017. J&J has 120 days to accept the offer and if the deal goes through it could close no later than early 2019. Fortive said it would finance the acquisition through debt or equity and with available cash. The company said it expects the deal to add to adjusted earnings in the first...

read more}

 
 
 
  Browse Report Categories  
 

Anesthesiology

Cosmetic Surgery

Diagnostics

Dialysis

Endoscopy

Gastrointestinal

Hearing Devices

Laparoscopy

Neurology

Oncology

Ophthalmics

Patient Monitoring

Pharmaceuticals

Soft Tissue Reinforcement and Regeneration

Ultrasound Imaging

Urology

Video Hi-Tech Navigation & Robotics

Women's Health

Wound & Tissue Care

BROWSE ALL

 
 
 

Latest Publications

 
 

Europe Market Report Suite For Digital Dentistry 2018 - MedSuite

Europe Market Report Suite For Cardiac Surgery Devices 2018 - MedSuite

Brazil Market Report Suite for Dental Prosthetics 2018 – MedSuite

US Market Report Suite for Overdentures and Implant Bridges 2018 – MedSuite

Europe Market Report Suite For Soft Tissue Reinforcement And Regeneration 2018 - MedSuite

US Market Report Suite for Video and Integrated Operating Room Equipment 2018 – MedSuite

US Market Report Suite for Vascular Access Devices and Accessories 2018 – MedSuite

US Market Report Suite for Infusion Therapy Devices 2018 – MedSuite

US Market Report Suite For Cardiac Surgery And Heart Valve Devices 2018 - MedSuite

Mexico Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Brazil Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

Argentina Market Report Suite For Minimally Invasive Spinal Implants 2018 - MedSuite

US Market Report Suite For Interventional Cardiology Devices 2018 - MedSuite

 
  View More  
   
 
 
 
 

Upcoming Publications

 
 

Europe Market Report Suite for Dental Prosthetics 2018 – MedSuite

Mexico Market Report Suite for Dental Prosthetics 2018 – MedSuite

Argentina Market Report Suite for Dental Prosthetics 2018 – MedSuite

Mexico Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Argentina Market Report Suite For Spinal Implants and VCF Devices 2018 - MedSuite

Brazil Market Report Suite For Spinal Implants And Vertebral Compression Fracture Devices 2018 - MedSuite

Europe Market Report Suite for Small Bone and Joint Orthopedic Devices 2018 - MedSuite

 
  View More  
     
 
 
 
Search All iData Report Categories
 
  WEBSITE | ABOUT | Blog | CONTACT | STAY CONNECTED facebook twitter linkedin  
 
iData Research | 308 - 4211 Kingsway, Burnaby BC, V5H 1Z6 | Tel: 604-266-6933 | info@idataresearch.net

Click here to unsubscribe from the iData Monthly Newsletter